Načítá se...
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
The transmembrane chemokines CX3CL1/fractalkine and CXCL16 are widely expressed in different types of tumors, often without an appropriate expression of their classical receptors. We observed that receptor-negative cancer cells could be stimulated by the soluble chemokines. Searching for alternative...
Uloženo v:
| Vydáno v: | eLife |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
eLife Sciences Publications, Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739769/ https://ncbi.nlm.nih.gov/pubmed/26796342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.10820 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|